Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1991-9-4
|
pubmed:abstractText |
We tested the hypothesis that dysfunction of vascular endothelium, indicated by an increase in plasma level of von Willebrand factor (vWF), is present in patients with insulin-dependent diabetes mellitus (IDDM) who develop diabetic nephropathy (DN). DN was classified as absent (urinary albumin excretion [UAE] rate less than 15 microgram/min), incipient (UAE rate 15-200 micrograms/min), or clinical (UAE rate greater than 200 micrograms/min). We followed a cohort of 59 patients for a median of 3 yr. At baseline, 52 patients had no DN, 6 had incipient DN, and 1 had clinical DN. At follow-up, 38 patients had no DN (group 1). Incipient DN had developed in 14 patients and worsened in 3 patients. Clinical DN had worsened in 1 patient. Together, these 18 patients comprised group 2. A decrease in UAE was observed in the remaining three patients with incipient DN at baseline (group 3). In group 1, vWF--measured by immunoelectrophoresis and expressed as a percentage of normal--increased slightly (median 10%, range -43 to 145, P = 0.009). In group 2, vWF increased in all patients (median 80%, range 14 to 206 [corrected], P = 0.0002 vs. baseline and group 1). In group 3, vWF decreased (median -19%, range -44 to -18). After correction for possible confounders, i.e., age, varying duration of follow-up, and initial level of vWF, the difference in vWF change between groups 1 and 2 remained significant (P = 0.009). Poor glycemic control at baseline, estimated by glycosylated hemoglobin, was a significant predictor of increases in vWF in both group 1 and groups 1 and 2 combined.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Creatinine,
http://linkedlifedata.com/resource/pubmed/chemical/Factor VIII,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
971-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1907250-Adult,
pubmed-meshheading:1907250-Albuminuria,
pubmed-meshheading:1907250-Biological Markers,
pubmed-meshheading:1907250-Blood Pressure,
pubmed-meshheading:1907250-Cholesterol,
pubmed-meshheading:1907250-Creatinine,
pubmed-meshheading:1907250-Diabetes Mellitus, Type 1,
pubmed-meshheading:1907250-Diabetic Nephropathies,
pubmed-meshheading:1907250-Factor VIII,
pubmed-meshheading:1907250-Female,
pubmed-meshheading:1907250-Follow-Up Studies,
pubmed-meshheading:1907250-Hemoglobin A, Glycosylated,
pubmed-meshheading:1907250-Humans,
pubmed-meshheading:1907250-Male,
pubmed-meshheading:1907250-Middle Aged,
pubmed-meshheading:1907250-Smoking,
pubmed-meshheading:1907250-von Willebrand Factor
|
pubmed:year |
1991
|
pubmed:articleTitle |
von Willebrand factor and development of diabetic nephropathy in IDDM.
|
pubmed:affiliation |
Department of Internal Medicine, Bergweg Municipal Hospital, Rotterdam, Netherlands.
|
pubmed:publicationType |
Journal Article
|